Arthritis Pain Relief

Add Info

Arthritis Pain Relief Recall

Get an alert when a recall is issued.

Ask a Question

Questions & Answers

Add Info

Side Effects & Adverse Reactions

For external use only

Condition worsens
Redness is present
Irritation develops
Symptoms persist for more than 7 days or clear up and occur again within a few days

Add Info

Legal Issues

There is currently no legal information available for this drug.

Add Info

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Add Info

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

Add Info

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Add Info

Uses

Temporarily relieves minor pain associated with:

arthritis
simple backache
muscle strains
muscle sprains
bruises
cramps

Add Info

History

There is currently no drug history available for this drug.

Add Info

Other Information

There are no additional details available for this product.

Sources

Arthritis Pain Relief Manufacturers

Cvs

Arthritis Pain Relief | Cvs

Adults and children over 18 years:

Apply to affected area Massage into painful area until thoroughly absorbed Repeat as necessary, but no more than 3 to 4 times daily IF MEDICINE COMES IN CONTACT WITH HANDS, WASH WITH SOAP AND WATER

Children 18 years or younger: ask a doctor

No Recall
Cvs Pharmacy

Arthritis Pain Relief | Cvs Pharmacy

• do not take more than directed (see overdose warning)
adults

▪ take 2 geltabs every 8 hours. Swallow only one geltab at a time.
▪ take a sip of water before swallowing each geltab and wash each geltab down with water (up to a full 8 oz. glass).
▪ swallow whole; do not crush, chew, split or dissolve
▪ do not take more than 6 geltabs in 24 hours
▪ do not use for more than 10 days unless directed by a doctor

under 18 years of age

▪ ask a doctor

No Recall
Hannaford Brothers Company

Arthritis Pain Relief | Hannaford Brothers Company

do not take more than directed (see overdose warning) adults take 2 caplets every 8 hours with water swallow whole – do not crush, chew or dissolve do not take more than 6 caplets in 24 hours do not use for more than 10 days unless directed by a doctor under 18 years of age ask a doctor

No Recall
Hyvee Inc

Arthritis Pain Relief | Cardinal Health

The dose of any local anesthetic administered varies with the anesthetic procedure, the area to be anesthetized, the vascularity of the tissues, the number of neuronal segments to be blocked, the depth of anesthesia and degree of muscle relaxation required, the duration of anesthesia desired, individual tolerance, and the physical condition of the patient. The smallest dose and concentration required to produce the desired result should be administered. Dosages of Sensorcaine should be reduced for elderly and/or debilitated patients and patients with cardiac and/or liver disease. The rapid injection of a large volume of local anesthetic solution should be avoided and fractional (incremental) doses should be used when feasible.

For specific techniques and procedures, refer to standard textbooks.

There have been adverse event reports of chondrolysis in patients receiving intra-articular infusions of local anesthetics following arthroscopic and other surgical procedures. Sensorcaine is not approved for this use (see WARNINGS and DOSAGE AND ADMINISTRATION).

In recommended doses, Sensorcaine (bupivacaine HCl) produces complete sensory block, but the effect on motor function differs among the three concentrations.

0.25%—when used for caudal, epidural, or peripheral nerve block, produces incomplete motor block. Should be used for operations in which muscle relaxation is not important, or when another means of providing muscle relaxation is used concurrently. Onset of action may be slower than with the 0.5% or 0.75% solutions.

0.5%—provides motor blockade for caudal, epidural, or nerve block, but muscle relaxation may be inadequate for operations in which complete muscle relaxation is essential.

0.75%—produces complete motor block. Most useful for epidural block in abdominal operations requiring complete muscle relaxation, and for retrobulbar anesthesia. Not for obstetrical anesthesia.

The duration of anesthesia with Sensorcaine is such that for most indications, a single dose is sufficient.

Maximum dosage limit must be individualized in each case after evaluating the size and physical status of the patient, as well as the usual rate of systemic absorption from a particular injection site. Most experience to date is with single doses of Sensorcaine up to 225 mg with epinephrine 1:200,000 and 175 mg without epinephrine; more or less drug may be used depending on individualization of each case.

These doses may be repeated up to once every three hours. In clinical studies to date, total daily doses have been up to 400 mg. Until further experience is gained, this dose should not be exceeded in 24 hours. The duration of anesthetic effect may be prolonged by the addition of epinephrine.

The dosages in Table 1 have generally proved satisfactory and are recommended as a guide for use in the average adult. These dosages should be reduced for elderly or debilitated patients. Until further experience is gained, Sensorcaine is not recommended for pediatric patients younger than 12 years. Sensorcaine is contraindicated for obstetrical paracervical blocks, and is not recommended for intravenous regional anesthesia (Bier Block).
Use in Epidural Anesthesia
During epidural administration of Sensorcaine, 0.5% and 0.75% solutions should be administered in incremental doses of 3 mL to 5 mL with sufficient time between doses to detect toxic manifestations of unintentional intravascular or intrathecal injection. In obstetrics, only the 0.5% and 0.25% concentrations should be used; incremental doses of 3 mL to 5 mL of the 0.5% solution not exceeding 50 mg to 100 mg at any dosing interval are recommended. Repeat doses should be preceded by a test dose containing epinephrine if not contraindicated. Use only the single dose ampules and single dose vials for caudal or epidural anesthesia; the multiple dose vials contain a preservative and therefore should not be used for these procedures.
Use in Dentistry
The 0.5% concentration with epinephrine is recommended for infiltration and block injection in the maxillary and mandibular area when a longer duration of local anesthetic action is desired, such as for oral surgical procedures generally associated with significant postoperative pain. The average dose of 1.8 mL (9 mg) per injection site will usually suffice; an occasional second dose of 1.8 mL (9 mg) may be used if necessary to produce adequate anesthesia after making allowance for 2 to 10 minutes onset time (see CLINICAL PHARMACOLOGY). The lowest effective dose should be employed and time should be allowed between injections; it is recommended that the total dose for all injection sites, spread out over a single dental sitting, should not ordinarily exceed 90 mg for a healthy adult patient (ten 1.8 mL injections of 0.5% sensorcaine with epinephrine). Injections should be made slowly and with frequent aspirations. Until further experience is gained, sensorcaine in dentistry is not recommended for pediatric patients younger than 12 years.

Unused portions of solution not containing preservatives, i.e., those supplied in single dose ampules and single dose vials, should be discarded following initial use.

This product should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit. Solutions which are discolored or which contain particulate matter should not be administered.

TABLE 1. Recommended Concentrations and Doses of Sensorcaine (bupivacaine HCl) Injections

Each Dose

Type of Block

Conc.

(mL)

(mg)

Motor Block1

Local Infiltration

0.25%4

up to max.

up to max.

            —

Epidural

0.75%2,4

10 to 20

75 to 150

complete

0.5%4

10 to 20

50 to 100

moderate to complete

0.25%4

10 to 20

25 to 50

partial to moderate

Caudal

0.5%4

15 to 30

75 to 150

moderate to complete

0.25%4

15 to 30

37.5 to 75

moderate

Peripheral Nerves

0.5%4

5 to max.

25 to max.

moderate to complete

0.25%4

5 to max.

12.5 to max.

moderate to complete

Retrobulbar3

0.75%4

2 to 4

15 to 30

complete

Sympathetic

0.25%

20 to 50

50 to 125

            —

Dental3

0.5% w/epi

1.8 to 3.6 per site

9 to 18 per site

            —

Epidural3

0.5%

2 to 3

10 to 15

            —

1 With continuous (intermittent) techniques, repeat doses increase the degree of motor block. The first repeat dose of 0.5% may produce complete motor block. Intercostal nerve block with 0.25% may also produce complete motor block for intra-abdominal surgery.

2 For single dose use, not for intermittent epidural technique. Not for obstetrical anesthesia.

3 See PRECAUTIONS.

4 Solutions with or without epinephrine.
Use in Epidural Anesthesia
During epidural administration of Sensorcaine, 0.5% and 0.75% solutions should be administered in incremental doses of 3 mL to 5 mL with sufficient time between doses to detect toxic manifestations of unintentional intravascular or intrathecal injection. In obstetrics, only the 0.5% and 0.25% concentrations should be used; incremental doses of 3 mL to 5 mL of the 0.5% solution not exceeding 50 mg to 100 mg at any dosing interval are recommended. Repeat doses should be preceded by a test dose containing epinephrine if not contraindicated. Use only the single dose ampules and single dose vials for caudal or epidural anesthesia; the multiple dose vials contain a preservative and therefore should not be used for these procedures.
Use in Dentistry
The 0.5% concentration with epinephrine is recommended for infiltration and block injection in the maxillary and mandibular area when a longer duration of local anesthetic action is desired, such as for oral surgical procedures generally associated with significant postoperative pain. The average dose of 1.8 mL (9 mg) per injection site will usually suffice; an occasional second dose of 1.8 mL (9 mg) may be used if necessary to produce adequate anesthesia after making allowance for 2 to 10 minutes onset time (see CLINICAL PHARMACOLOGY). The lowest effective dose should be employed and time should be allowed between injections; it is recommended that the total dose for all injection sites, spread out over a single dental sitting, should not ordinarily exceed 90 mg for a healthy adult patient (ten 1.8 mL injections of 0.5% sensorcaine with epinephrine). Injections should be made slowly and with frequent aspirations. Until further experience is gained, sensorcaine in dentistry is not recommended for pediatric patients younger than 12 years.

Unused portions of solution not containing preservatives, i.e., those supplied in single dose ampules and single dose vials, should be discarded following initial use.

This product should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit. Solutions which are discolored or which contain particulate matter should not be administered.

TABLE 1. Recommended Concentrations and Doses of Sensorcaine (bupivacaine HCl) Injections

Each Dose

Type of Block

Conc.

(mL)

(mg)

Motor Block1

Local Infiltration

0.25%4

up to max.

up to max.

            —

Epidural

0.75%2,4

10 to 20

75 to 150

complete

0.5%4

10 to 20

50 to 100

moderate to complete

0.25%4

10 to 20

25 to 50

partial to moderate

Caudal

0.5%4

15 to 30

75 to 150

moderate to complete

0.25%4

15 to 30

37.5 to 75

moderate

Peripheral Nerves

0.5%4

5 to max.

25 to max.

moderate to complete

0.25%4

5 to max.

12.5 to max.

moderate to complete

Retrobulbar3

0.75%4

2 to 4

15 to 30

complete

Sympathetic

0.25%

20 to 50

50 to 125

            —

Dental3

0.5% w/epi

1.8 to 3.6 per site

9 to 18 per site

            —

Epidural3

0.5%

2 to 3

10 to 15

            —

1 With continuous (intermittent) techniques, repeat doses increase the degree of motor block. The first repeat dose of 0.5% may produce complete motor block. Intercostal nerve block with 0.25% may also produce complete motor block for intra-abdominal surgery.

2 For single dose use, not for intermittent epidural technique. Not for obstetrical anesthesia.

3 See PRECAUTIONS.

4 Solutions with or without epinephrine.

No Recall
Meijer Distribution Inc

Arthritis Pain Relief | Greenbrier International, Inc.

do not use more than directed adults and children 12 years and over take 2 tablets every 4 hours do not take more than 10 caplets in 24 hours children under 12 years: ask a doctor

No Recall
Publix Super Markets Inc

Arthritis Pain Relief | Apotheca Company

Directions: 10 drops orally, 3 times a day. Consult a physician for use in children under 12 years of age.

No Recall
Hyvee Inc

Arthritis Pain Relief | Hyvee Inc

• do not take more than directed (see overdose warning)
adults
• take 2 caplets every 8 hours with water • swallow whole; do not crush, chew, split or dissolve • do not take more than 6 caplets in 24 hours • do not use for more than 10 days unless directed by a doctor
under 18 years of age
• ask a doctor

No Recall
Cvs Pharmacy

Arthritis Pain Relief | Cvs Pharmacy

do not take more than directed (see overdose warning) adults ▪ take 2 geltabs every 8 hours. Swallow only one geltab at a time.
▪ take a sip of water before swallowing each geltab and wash each geltab down with water (up to a full 8 oz. glass).
▪ swallow whole - do not crush, chew, split or dissolve
▪ do not take more than 6 geltabs in 24 hours
▪ do not use for more than 10 days unless directed by a doctor
under 18 years of age ▪ ask a doctor

No Recall
Kroger Company

Arthritis Pain Relief | Ncs Healthcare Of Ky, Inc Dba Vangard Labs

2.1 Acute Coronary Syndrome
Clopidogrel tablets USP can be administered with or without food [see Clinical Pharmacology (12.3)].
For patients with non-ST-elevation ACS (UA/NSTEMI), initiate clopidogrel tablets USP with a single 300 mg oral loading dose and then continue at 75 mg once daily. Initiate aspirin (75 to 325 mg once daily) and continue in combination with clopidogrel tablets USP [see Clinical Studies (14.1)]. For patients with STEMI, the recommended dose of clopidogrel tablets USP is 75 mg once daily orally, administered in combination with aspirin (75 to 325 mg once daily), with or without thrombolytics. Clopidogrel tablets USP may be initiated with or without a loading dose [see Clinical Studies (14.1)]. 2.2 Recent MI, Recent Stroke, or Established Peripheral Arterial Disease
The recommended daily dose of clopidogrel tablets USP is 75 mg once daily orally, with or without food [see Clinical Pharmacology (12.3)].
2.3 CYP2C19 Poor Metabolizers
CYP2C19 poor metabolizer status is associated with diminished antiplatelet response to clopidogrel. Although a higher dose regimen in poor metabolizers increases antiplatelet response [see Clinical Pharmacology (12.5)], an appropriate dose regimen for this patient population has not been established.
2.4 Use With Proton Pump Inhibitors (PPI)
Avoid using omeprazole or esomeprazole with clopidogrel tablets USP. Omeprazole and esomeprazole significantly reduce the antiplatelet activity of clopidogrel tablets USP. When concomitant administration of a PPI is required, consider using another acid-reducing agent with minimal or no CYP2C19 inhibitory effect on the formation of clopidogrel active metabolite [see Warnings and Precautions (5.1), Drug Interactions (7.1) and Clinical Pharmacology (12.3)].

No Recall
Meijer Distribution Inc

Arthritis Pain Relief | I-health, Inc.

Directions
Adults and children 12 years or older: Take 2 tablets 3 times daily with or after meals as needed for up to two days. Take with a full glass of water. Children under 12: Do not use without consulting a doctor Do not use for more than 2 days (12 tablets) without consulting a doctor.

No Recall